Necessity of ascorbic acid in the radioligand binding assay for [ 3H]5-hydroxytryptamine
Evidence is presented to suggest that ascorbic add is required in the radioligand binding assay for [ 3H]5-hydroxytryptamine ([ 3H]5-HT, [ 3H]serotonin). In the absence of ascorbic acid, oxidation of [ 3H]5-HT occurred if the radioligand solution was left on ice for 1 or 3 hr. The oxidative products...
Gespeichert in:
Veröffentlicht in: | Neuropharmacology 1986-08, Vol.25 (8), p.869-875 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Evidence is presented to suggest that ascorbic add is required in the radioligand binding assay for [
3H]5-hydroxytryptamine ([
3H]5-HT, [
3H]serotonin). In the absence of ascorbic acid, oxidation of [
3H]5-HT occurred if the radioligand solution was left on ice for 1 or 3 hr. The oxidative products were detectable by thin-layer chromatography. They increased the binding significantly, although there was only slight oxidation (< 1%) of the [
3H]5-HT. When ascorbic add was not used in the radioligand binding assay for [
3H]5-HT, even though [
3H]5-HT was prepared immediately before incubating with the membranes from the cortex of the rat, the binding also increased. The increased binding of [
3H]5-HT had a low affinity (k
d = 14 nM) and high
B
max (1180 fmol/mg protein), compared to that in the presence of ascorbic add (K
d = 5 nM;
B
max = 210 fmol/mg protein). However, the increased binding was not receptor-related because the additional radioactivity was not displaceable by excess of unlabelled 5-HT (10μM) or
d-LSD (
d-lysergic add iethylamide) and anomalous “spedfic binding” occurred in boiled membranes from cortex, in which the binding sites for 5-HT were destroyed. These results suggest that oxidation of [
3H]5-HT may occur during the incubation with membranes and that ascorbic add is therefore required as an antioxidant. |
---|---|
ISSN: | 0028-3908 1873-7064 |
DOI: | 10.1016/0028-3908(86)90013-4 |